CROI 2019 Program and Conference Information

Oral Sessions

36 FACTOR X INHIBITION REDUCES COAGULATION BUT NOT INFLAMMATION IN PERSONSWITHHIV Jason V. Baker, Julian Wolfson, Tess Peterson, Kelly Garcia-Myers, Jonathan Klaphake, Micah Mooberry, Matthew Gissel, Kathleen Brummel- Ziedins, Irini Sereti, Nigel Key, Russell Tracy 37 LB SAFETY, TOLERABILITY AND IMMUNOLOGIC ACTIVITY OF RUXOLITINIB ADDED TO SUPPRESSIVE ART 11:45 Vincent C. Marconi, Carlee Moser, Christina Gavegnano, Athe Tsibris, Amy Kantor, Edgar T. Overton, Charles W. Flexner, Peter W. Hunt, Rafick-Pierre Sekaly, Carlos del Rio, Michael M. Lederman, Randall Tressler, Steven G. Deeks, Jeffrey J. Lennox, Raymond F. Schinazi Oral Abstract O-04 CRITICAL ISSUES IN MATERNAL AND PEDIATRIC HEALTH Room 6C 10:00 AM - 12:00 PM Oral Abstract Moderators Sharon Nachman, Stony Brook University, Stony Brook, USA Bolanle Oyeledun, Centre for Integrated Health Programs, Abuja, Nigeria 39 LB RANDOMIZED TRIAL OF RALTEGRAVIR-ART VS EFAVIRENZ-ART WHEN INITIATED DURING PREGNANCY Mark Mirochnick, David E. Shapiro, Leavitt Morrison, Lisa Frenkel, Nahida Chakhtoura, George K. Siberry, Brookie Best, Maria Leticia S. Cruz, Blandina T. Mmbaga, Jose Henrique S. Pilotto, Avy Violari, Sinart Prommas, Esau Joao, for the NICHD P1081 Protocol Team 40 LB RCT OF DOLUTEGRAVIR VS EFAVIRENZ-BASED THERAPY INITIATED IN LATE PREGNANCY: DOLPHIN-2 Kenneth Kintu, Thoko Malaba, Jesca Nakibuka, Christiana Papamichael, Angela Colbers, Kay Seden, Victoria Watson, Helen Reynolds, Duolao Wang, Catriona Waitt, Catherine Orrell, Mohammed Lamorde, Landon Myer, Saye Khoo, for the DolPHIN-2 Study Group MATERNAL HBV VIREMIA IS ASSOCIATEDWITH ADVERSE INFANT OUTCOMES INHIV/HBVWOMEN Debika Bhattacharya, Rong Guo, Chi-hong Tseng, Lynda Emel, Ren Sun, Shih-Hsin Chiu, Lynda Stranix-Chibanda, Tsungai Chipato, Neaka Z. Mohtashemi, Kenneth Kintu, Karim P. Manji, Dhayendre Moodley, Chloe Thio, Yvonne Maldonado, Judith S. Currier 10:00 10:30 41 Robert Ntozini, Jaya Chandna, Ceri Evans, Gwendoline Kandawasvika, Bernard Chasekwa, Florence D. Majo, Naume Tavengwa, Kuda Mutasa, Batsirai Mutasa, Lawrence Moulton, Jean Humphrey, Andrew Prendergast, Melissa Gladstone, for the SHINE Trial Team UNIQUE IMMUNOLOGICAL ANDVIROLOGICAL FEATURES OF EARLY TREATED HIV-INFECTED NEWBORNS Pilar Garcia Broncano, Kevin Einkauf, Ce Gao, Shivaali Maddali, Chenyang Jiang, Kenneth Maswabi, Gbolahan Ajibola, Sikhulile Moyo, Terence Mohammed, Thabani Ncube, Joseph Makhema, Kathleen M. Powis, Daniel R. Kuritzkes, Roger L. Shapiro, Mathias Lichterfeld 43 10:45 11:00 42 IMPACT OF IMPROVED NUTRITION/SANITATION ON NEURODEVELOPMENT OF HIV-EXPOSED CHILDREN 11:30

Oral Sessions • Tuesday 10:15

CROI 2019 34